超声引导下的区域阻滞对胸科手术患者术后疼痛的影响

注册号:

Registration number:

ChiCTR2000029553 

最近更新日期:

Date of Last Refreshed on:

2020-02-04 14:47:40 

注册时间:

Date of Registration:

2020-02-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

超声引导下的区域阻滞对胸科手术患者术后疼痛的影响

Public title:

The effect of regional block under ultrasonic guidance on the postoperative pain of thoracic surgery

注册题目简写:

English Acronym:

研究课题的正式科学名称:

超声引导下的区域阻滞对胸科手术患者术后疼痛的影响

Scientific title:

The effect of regional block under ultrasonic guidance on the postoperative pain after thoracic surgery

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

康芳 

研究负责人:

陈旭 

Applicant:

Kang Fang 

Study leader:

Chen Xu 

申请注册联系人电话:

Applicant telephone:

+86 18155127799

研究负责人电话:

Study leader's
telephone:

+86 18326108020

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

kangfang199771@163.com

研究负责人电子邮件:

Study leader's E-mail:

1561476059@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省合肥市天鹅湖路1号中国科技大学附属第一医院麻醉科

研究负责人通讯地址:

安徽省合肥市天鹅湖路1号

Applicant address:

1 Tian'ehu Road, Hefei, Anhui, China

Study leader's address:

1 Tian'ehu Road, Hefei, Anhui, China

申请注册联系人邮政编码:

Applicant postcode:

233000

研究负责人邮政编码:

Study leader's postcode:

233000

申请人所在单位:

中国科技大学附属第一医院(安徽省立医院)

Applicant's institution:

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

研究负责人所在单位:

中国科技大学附属第一医院(安徽省立医院)

Affiliation of the Leader:

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2019KY伦审第108号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

安徽省立医院医学研究伦理委员会

Name of the ethic committee:

Anhui Provincial Hospital Ethics Committee for Medical Research

伦理委员会批准日期:

Date of approved by ethic committee:

2019-10-14 00:00:00

伦理委员会联系人:

许梦珊

Contact Name of the ethic committee:

Xu Mengshan

伦理委员会联系地址:

安徽省合肥市庐江路9号

Contact Address of the ethic committee:

9 Lujiang Road, Hefei, Anhui, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 551-6228293

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

安徽省立医院南区

Primary sponsor:

South District of Anhui Provincial Hospital

研究实施负责(组长)单位地址:

合肥市天鹅湖路1号

Primary sponsor's address:

1 Tian'ehu Road, Hefei, Anhui, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

合肥

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽省立医院南区

具体地址:

天鹅湖路1号

Institution
hospital:

South District of Anhui Provincial Hospital

Address:

1 Tian'ehu Road

经费或物资来源:

自筹

Source(s) of funding:

self-funded

研究疾病:

食管癌术后疼痛  

Target disease:

Postoperative pain of esophageal cancer patient

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1.术前焦虑和疼痛敏感度对胸科手术患者术后疼痛的影响; 2.超声引导下的区域阻滞对胸科手术患者术后疼痛的影响。  

Objectives of Study:

1. The effect of preoperative anxiety and pain sensitivity on the postoerative pain of esophageal cancer patient; 2. The effect of regional block under ultrasonic guidance on the postoperative pain of esophageal cancer patients

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)有精神疾病史或因其他原因交流困难;
(2)酒精依赖或长期应用镇痛药物史;
(3)严重系统性疾病且控制不良;
(4)术后入ICU;
(5)术后3月内再次手术或死亡;
(6)术前食管癌放疗史。

Exclusion criteria:

1. History of mental illness or communication difficulties for other reasons;
2. Alcohol dependence or a long history of analgesics;
3. Severe systemic disease and poor control;
4. Transfer into ICU postoperatively for unpredicted reason.

研究实施时间:

Study execute time:

From 2020-02-10 00:00:00 To 2021-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-02-10 00:00:00 To 2021-06-30 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

50

Group:

control group

Sample size:

干预措施:

干预措施代码:

0

Intervention:

Nil

Intervention code:

组别:

试验组1

样本量:

50

Group:

experimental group 1

Sample size:

干预措施:

胸椎旁阻滞

干预措施代码:

1

Intervention:

thoracic paravertebral block

Intervention code:

组别:

试验组2

样本量:

50

Group:

experimental group 2

Sample size:

干预措施:

竖脊肌阻滞

干预措施代码:

2

Intervention:

Erector spinal block

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽 

市(区县):

合肥 

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽省立医院 

单位级别:

三级甲等 

Institution
hospital:

Anhui Provical Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

汉密尔顿焦虑评分

指标类型:

主要指标

Outcome:

Hamilton anxiety score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛敏感性评分

指标类型:

主要指标

Outcome:

pain sensitivity score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后急性疼痛评分

指标类型:

主要指标

Outcome:

posteroperative acute pain

Type:

Primary indicator

测量时间点:

拔管后1小时,术后1天,术后2天,术后3天

测量方法:

Measure time point of outcome:

1h after extubation, 1-day, 2-day, 3-day after surgery

Measure method:

指标中文名:

镇痛药物用量

指标类型:

主要指标

Outcome:

Analgesic consumption

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后慢性疼痛

指标类型:

主要指标

Outcome:

chronic pain after surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由不知情者采用随机数字表法产生。

Randomization Procedure (please state who generates the random number sequence and by what method):

The random number table method is used by uninformed person.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Not stated

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2021年6月,中国临床研究注册中心

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

June,2021,Chinese Clincal trial registry

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case record form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-02-04 14:47:40